The New Colonialism Does Not Arrive With Guns — It Arrives With Needles.Kenya’s exploding trade in blood and biological samples is not merely a medical scandal. It is the naked anatomy of a global economic order that survives by feeding on desperation. Behind the language of “research partnerships,” “medical innovation,” and “biotechnology exports” lies a brutal reality: the bodies of the poor are being converted into raw material for international profit while the same communities are abandoned inside collapsing healthcare systems.
The investigation into the export of blood, plasma, urine, stool, and tissue samples reported in today’s The Standard Newspaper, reveals something far larger than regulatory weakness. It exposes a system in which scarcity is not an accident but a business model. Kenya suffers chronic blood shortages in public hospitals, yet thousands of kilograms of biological material continue flowing into foreign markets worth tens of millions of dollars. This contradiction is not irrational. It is perfectly logical within an economy designed to extract value from human vulnerability.
The numbers alone are staggering. Biological exports reportedly rose from roughly $10.8 million in 2020 to more than $72 million in 2024. Meanwhile, hospitals continue rationing blood to mothers in labour, accident victims, cancer patients, and children requiring emergency transfusions. The country bleeds twice: first from its people, then from its institutions. And still the industry grows.
Not because the public demanded it. Not because communities benefit from it. But because there is immense profit in turning human suffering into export inventory.
Poverty Has Become a Harvesting Tool
The most chilling feature of this trade is not the export itself. Nations have long exchanged medical materials for research. The horror lies in the social conditions under which this extraction occurs.
When unemployed citizens, struggling students, and economically desperate populations become the primary reservoir for biological collection, consent becomes dangerously contaminated by survival. A hungry man does not negotiate freely. A mother facing eviction does not enter a laboratory as an equal participant. Poverty distorts choice until exploitation can masquerade as agreement.
This is how modern extraction operates. It no longer storms villages with chains and rifles. It arrives wearing lab coats, carrying consent forms, and speaking the polished language of global health cooperation. The violence is cleaner now — bureaucratic, procedural, sanitized. But its architecture remains the same: wealth flows outward while vulnerability stays behind.
The investigation suggests many donors may not fully understand how their samples are stored, commercialized, or reused internationally. That matters profoundly. Biological material is not an ordinary commodity. Blood carries genetic information, medical histories, and research value that can generate patents, pharmaceuticals, and billion-dollar innovations far beyond the awareness or benefit of the donor.
This creates a grotesque imbalance. The poor surrender fragments of their bodies for survival money while multinational industries accumulate scientific capital and commercial advantage. One side donates out of desperation. The other profits through infrastructure, patents, and market control.
Such systems are often defended as “mutually beneficial.” Yet if the relationship were truly equal, Kenya would not simultaneously endure catastrophic shortages in its own healthcare system. The country supplying the blood would not be unable to save its own citizens. That is the scandal beneath the scandal.
The Market Has Invaded Human Flesh
What this investigation ultimately reveals is the terrifying expansion of market logic into the human body itself. Under this arrangement, nothing is sacred because everything can be monetized. Blood becomes inventory. Tissue becomes export data. The sick poor become suppliers in a biomedical supply chain designed elsewhere and owned elsewhere. This is not healthcare. It is commodification elevated into doctrine.
The most dangerous aspect of this system is that it normalizes inequality while disguising it as development. Governments celebrate export growth figures while ignoring the social wreckage beneath them. International actors praise scientific collaboration while avoiding serious questions about coercion, ownership, and benefit distribution.
Meanwhile, public institutions weaken. Hospitals remain underfunded. National blood reserves collapse. Medical workers improvise under permanent scarcity. Entire populations are disciplined into accepting crisis as normal while elite networks convert that crisis into opportunity.
That is why the issue cannot be solved merely through better regulation or stricter consent forms. Those measures are necessary but insufficient. The deeper problem is structural. Essential healthcare systems have been subordinated to profit incentives and external market demand. Human life has been reorganized around commercial extraction rather than social need. A society governed this way inevitably produces moral catastrophe.
A Nation Must Refuse to Sell Its People in Pieces
The answer is not isolationism, nor hostility to science, nor rejection of medical research. Scientific advancement matters. International cooperation matters. But no ethical society can permit a situation where citizens become reservoirs of exportable biological wealth while remaining trapped inside collapsing public healthcare systems. The solution begins by reversing the hierarchy of priorities.
Human health must cease to be governed primarily by commercial logic. Strategic biological resources should be placed under strict democratic public control, insulated from predatory market incentives and foreign dependency structures. Communities providing biological materials must become direct beneficiaries of the scientific and economic value generated from them. Public hospitals, national blood systems, and healthcare infrastructure must be funded not as charitable obligations, but as sovereign national imperatives.
Most importantly, poverty itself must stop being the engine that powers participation. A society that forces citizens to monetize their own bodies in order to survive has already crossed into moral failure.
A nation cannot call itself free while its people are reduced to export commodities measured in kilograms, invoices, and shipment manifests.
When blood becomes business, humanity itself enters the marketplace — and the poor always pay the highest price. This is capitalism, a system which has outlived its usefulness and therefore needs to be abolished.
Okoth Osewe
About the Author
